Conmed (CNMD) Operating Income Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.82% |
| Dec 31, 2025 | 8.20% |
| Sep 30, 2025 | -16.57% |
| Jun 30, 2025 | 30.58% |
| Mar 31, 2025 | 3.91% |
| Dec 31, 2024 | 13.49% |
| Sep 30, 2024 | 25.70% |
| Jun 30, 2024 | 20.35% |
| Mar 31, 2024 | 24.65% |
| Dec 31, 2023 | 14.21% |
| Sep 30, 2023 | 21.33% |
| Jun 30, 2023 | 10.45% |
| Mar 31, 2023 | -5.97% |
| Dec 31, 2022 | -15.41% |
| Sep 30, 2022 | 12.48% |
| Jun 30, 2022 | 13.86% |
| Mar 31, 2022 | 61.54% |
| Dec 31, 2021 | 24.17% |
| Sep 30, 2021 | 14.04% |
| Jun 30, 2021 | 27.32% |
| Mar 31, 2021 | 41.51% |
| Dec 31, 2020 | 13.76% |
| Sep 30, 2020 | 14.64% |
| Jun 30, 2020 | -29.99% |
| Mar 31, 2020 | 3.76% |
| Dec 31, 2019 | 10.28% |
| Sep 30, 2019 | 53.60% |
| Jun 30, 2019 | 3.20% |
| Mar 31, 2019 | -7.63% |
| Dec 31, 2018 | 9.80% |
| Sep 30, 2018 | 5.53% |
| Jun 30, 2018 | 1.28% |
| Mar 31, 2018 | 1.71% |
| Dec 31, 2017 | 6.37% |
| Sep 30, 2017 | -0.93% |
| Jun 30, 2017 | -5.61% |
| Mar 31, 2017 | -16.51% |
| Dec 31, 2016 | 18.16% |
| Sep 30, 2016 | -2.78% |
| Jun 30, 2016 | -14.38% |
| Mar 31, 2016 | -27.16% |
| Dec 31, 2015 | -0.88% |
| Sep 30, 2015 | -0.48% |
| Jun 30, 2015 | -3.42% |